Hill-Rom Stock Forecast, Price & News

+0.26 (+0.19 %)
(As of 08/3/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume1.12 million shs
Average Volume448,760 shs
Market Capitalization$9.22 billion
P/E Ratio39.08
Dividend Yield0.69%
30 days | 90 days | 365 days | Advanced Chart
Receive HRC News and Ratings via Email

Sign-up to receive the latest news and ratings for Hill-Rom and its competitors with MarketBeat's FREE daily newsletter.

Hill-Rom logo

About Hill-Rom

Hill-Rom Holdings, Inc. operates as a medical technology company worldwide. It operates through Patient Support Systems, Front Line Care, and Surgical Solutions segments. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, patient mobility solutions, non-invasive therapeutic products and surfaces, and information technologies and software solutions, as well as sells equipment service contracts for its capital equipment. It also provides patient monitoring and diagnostics products, such as patient exam and diagnostics, patient monitoring, diagnostic cardiology, vision screening, and diagnostics products; and respiratory health products comprising non-invasive devices that provide respiratory support and assist patients in the mobilization of retained blockages. In addition, the company offers surgical solutions that include tables, lights, and pendants; and positioning devices for use in shoulder, hip, spinal, and lithotomy surgeries, as well as platform-neutral positioning accessories for operating room tables. It sells and rents products to acute and extended care facilities through direct sales force and distributors; sells and rents products directly to patients in the home; and sells products to primary care facilities through distributors. Hill-Rom Holdings, Inc. was founded in 1915 and is headquartered in Chicago, Illinois.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

2.14 out of 5 stars

Medical Sector

410th out of 1,309 stocks

Surgical & Medical Instruments Industry

43rd out of 121 stocks

Analyst Opinion: 1.4Community Rank: 4.5Dividend Strength: 1.7Insider Behavior: 2.5Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Hill-Rom (NYSE:HRC) Frequently Asked Questions

Is Hill-Rom a buy right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Hill-Rom in the last year. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Hill-Rom stock.
View analyst ratings for Hill-Rom
or view top-rated stocks.

What stocks does MarketBeat like better than Hill-Rom?

Wall Street analysts have given Hill-Rom a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Hill-Rom wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Hill-Rom's next earnings date?

Hill-Rom is scheduled to release its next quarterly earnings announcement on Friday, November 5th 2021.
View our earnings forecast for Hill-Rom

How were Hill-Rom's earnings last quarter?

Hill-Rom Holdings, Inc. (NYSE:HRC) posted its earnings results on Friday, July, 30th. The medical technology company reported $1.38 earnings per share for the quarter, topping analysts' consensus estimates of $1.35 by $0.03. The medical technology company earned $717.70 million during the quarter, compared to analysts' expectations of $708.33 million. Hill-Rom had a net margin of 8.12% and a trailing twelve-month return on equity of 21.74%. The firm's quarterly revenue was down 6.5% on a year-over-year basis. During the same period in the previous year, the company posted $1.95 EPS.
View Hill-Rom's earnings history

How has Hill-Rom's stock price been impacted by COVID-19 (Coronavirus)?

Hill-Rom's stock was trading at $89.15 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, HRC shares have increased by 55.6% and is now trading at $138.73.
View which stocks have been most impacted by COVID-19

How often does Hill-Rom pay dividends? What is the dividend yield for Hill-Rom?

Hill-Rom announced a quarterly dividend on Thursday, July 8th. Investors of record on Friday, September 17th will be given a dividend of $0.24 per share on Thursday, September 30th. This represents a $0.96 annualized dividend and a yield of 0.69%. The ex-dividend date is Thursday, September 16th.
View Hill-Rom's dividend history

Is Hill-Rom a good dividend stock?

Hill-Rom pays an annual dividend of $0.96 per share and currently has a dividend yield of 0.69%. Hill-Rom does not yet have a strong track record of dividend growth. The dividend payout ratio of Hill-Rom is 17.36%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Hill-Rom will have a dividend payout ratio of 15.07% next year. This indicates that Hill-Rom will be able to sustain or increase its dividend.
View Hill-Rom's dividend history.

What guidance has Hill-Rom issued on next quarter's earnings?

Hill-Rom issued an update on its FY21 earnings guidance on Friday, July, 30th. The company provided earnings per share guidance of $6.08-6.12 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $6.06. The company issued revenue guidance of ~$2.97-3.00 billion, compared to the consensus revenue estimate of $2.94 billion.

What price target have analysts set for HRC?

5 brokerages have issued 1-year price objectives for Hill-Rom's stock. Their forecasts range from $117.00 to $150.00. On average, they anticipate Hill-Rom's stock price to reach $136.40 in the next twelve months. This suggests that the stock has a possible downside of 1.7%.
View analysts' price targets for Hill-Rom
or view top-rated stocks among Wall Street analysts.

Who are Hill-Rom's key executives?

Hill-Rom's management team includes the following people:
  • Mr. John P. Groetelaars, Pres, CEO & Director (Age 54, Pay $2.39M)
  • Ms. Barbara W. Bodem, Sr. VP & CFO (Age 53, Pay $1.1M)
  • Ms. Deborah M. Rasin, Sr. VP, Chief Legal Officer & Sec. (Age 54, Pay $953.86k)
  • Mr. Andreas G. Frank, Sr. VP & Pres of Front Line Care business (Age 45, Pay $1.17M)
  • Mr. Paul S. Johnson, Sr. VP & Pres of Patient Support Systems (Age 56, Pay $1.06M)
  • Mr. Timothy P. Lawrence, Sr. VP of Operations (Age 58)
  • Mr. Richard M. Wagner, VP, Controller & CAO (Age 53)
  • Mr. Brian Lawrence, CTO & Sr. VP (Age 51)
  • Ms. Sue-Jean Lin, Chief Information Officer & Sr. VP
  • Ms. Mary Kay Ladone, Sr. VP of Corp. Devel., Strategy & Investor Relations (Age 46)

What is John P. Groetelaars' approval rating as Hill-Rom's CEO?

54 employees have rated Hill-Rom CEO John P. Groetelaars on Glassdoor.com. John P. Groetelaars has an approval rating of 82% among Hill-Rom's employees.

Who are some of Hill-Rom's key competitors?

What other stocks do shareholders of Hill-Rom own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hill-Rom investors own include Steel Dynamics (STLD), The Walt Disney (DIS), NVIDIA (NVDA), Square (SQ), PayPal (PYPL), salesforce.com (CRM), CVS Health (CVS), Micron Technology (MU), AbbVie (ABBV) and Bank of America (BAC).

What is Hill-Rom's stock symbol?

Hill-Rom trades on the New York Stock Exchange (NYSE) under the ticker symbol "HRC."

Who are Hill-Rom's major shareholders?

Hill-Rom's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Victory Capital Management Inc. (5.49%), Boston Trust Walden Corp (1.22%), Fisher Asset Management LLC (0.98%), Ceredex Value Advisors LLC (0.95%), Clark Capital Management Group Inc. (0.31%) and New York State Common Retirement Fund (0.20%). Company insiders that own Hill-Rom stock include Amy M Dodrill, Andreas G Frank, Deborah Rasin, Jeffrey F Dimodica, Mary Kay Ladone and Paul Sherwood Johnson.
View institutional ownership trends for Hill-Rom

Which institutional investors are selling Hill-Rom stock?

HRC stock was sold by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC, State of Michigan Retirement System, Alliancebernstein L.P., Arizona State Retirement System, Versor Investments LP, Chartwell Investment Partners LLC, and Deroy & Devereaux Private Investment Counsel Inc.. Company insiders that have sold Hill-Rom company stock in the last year include Andreas G Frank, Deborah Rasin, Jeffrey F Dimodica, Mary Kay Ladone, and Paul Sherwood Johnson.
View insider buying and selling activity for Hill-Rom
or view top insider-selling stocks.

Which institutional investors are buying Hill-Rom stock?

HRC stock was purchased by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Ceredex Value Advisors LLC, Dupont Capital Management Corp, New York State Common Retirement Fund, Boston Trust Walden Corp, Clark Capital Management Group Inc., Zurcher Kantonalbank Zurich Cantonalbank , and Livforsakringsbolaget Skandia Omsesidigt.
View insider buying and selling activity for Hill-Rom
or or view top insider-buying stocks.

How do I buy shares of Hill-Rom?

Shares of HRC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Hill-Rom's stock price today?

One share of HRC stock can currently be purchased for approximately $138.73.

How much money does Hill-Rom make?

Hill-Rom has a market capitalization of $9.22 billion and generates $2.88 billion in revenue each year. The medical technology company earns $223 million in net income (profit) each year or $5.53 on an earnings per share basis.

How many employees does Hill-Rom have?

Hill-Rom employs 10,000 workers across the globe.

What is Hill-Rom's official website?

The official website for Hill-Rom is www.hill-rom.com.

Where are Hill-Rom's headquarters?

Hill-Rom is headquartered at 130 East Randolph Street Suite 1000, Chicago IL, 60601.

How can I contact Hill-Rom?

Hill-Rom's mailing address is 130 East Randolph Street Suite 1000, Chicago IL, 60601. The medical technology company can be reached via phone at 312-819-7200 or via email at [email protected]

This page was last updated on 8/3/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.